Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
For the first time, U.S. CardioMEMS patients will be able to view pulmonary artery pressure (PAP) readings and receive personalized medication updates through the CardioGuide HF App. Rising PAP can signal worsening heart failure weeks before patients experience symptoms.
New capabilities help patients take a more active role in their care and stay connected to their care teams between doctor visits
October 5, 2026